Surishi Pharmaceuticals Introduces Longevity Science to Women's Healthcare
Apr 16, 2026
New Delhi [India], April 16: Surishi Pharmaceuticals Pvt. Ltd., a pioneering women's healthcare company headquartered in New Delhi, is taking a bold step forward bringing the emerging science of cellular longevity directly into the conversation around women's health in India. As the global medical community increasingly recognises NAD+ (Nicotinamide Adenine Dinucleotide) depletion as a root cause of accelerated ageing in women, Surishi Pharmaceuticals is championing the science of NMN supplementation and mitochondrial health as essential pillars of preventive women's care not a decade from now, but today.
Read More...
